Pimasertib Terminated Phase 2 Trials for Neoplasms, Hematologic / Acute Myeloid Leukemia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00957580Trial of Pimasertib in Hematological Malignancies